SOLTIVE SuperPulsed Laser Fibers, Model No. TFL-FBX200BS
FDA Device Recall #Z-0718-2024 — Class II — December 4, 2023
Recall Summary
| Recall Number | Z-0718-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | December 4, 2023 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Olympus Corporation of the Americas |
| Location | Center Valley, PA |
| Product Type | Devices |
| Quantity | 179 units |
Product Description
SOLTIVE SuperPulsed Laser Fibers, Model No. TFL-FBX200BS
Reason for Recall
Affected products may potentially have a breached sterile pouch seal. A breached sterile pouch seal may lead to minor procedure delays (if noticed prior to use) or patient infections (if not noticed prior to use in patient).
Distribution Pattern
Domestic distribution to the following states: AK AR AZ CA FL GA IA ID IN KS KY LA MA MI NC ND NE NJ NY OR PA SC SD TN TX VA WI International distribution to Canada, Latin America, and Europe.
Lot / Code Information
UDI-DI 00821925043985 Lot KR262848
Other Recalls from Olympus Corporation of the Americas
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1909-2026 | Class II | OER-ELITE Endoscope Reprocessor Connecting Tube... | Mar 25, 2026 |
| Z-1904-2026 | Class II | OER-ELITE Endoscope Reprocessor Connecting Tube... | Mar 25, 2026 |
| Z-1899-2026 | Class II | OER-ELITE Endoscope Reprocessor Connecting Tube... | Mar 25, 2026 |
| Z-1898-2026 | Class II | OER-ELITE Endoscope Reprocessor Connecting Tube... | Mar 25, 2026 |
| Z-1905-2026 | Class II | OER-ELITE Endoscope Reprocessor Connecting Tube... | Mar 25, 2026 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.